MSc Cancer Biology and Therapy
Overview
This programme is designed to provide a high level understanding of the theory and practice of cancer research and to connect cancer-related biomedical research with clinical applications.
The programme is taught by both internationally renowned biomedical scientists and clinicians in practice, to provide in-depth scientific knowledge of the molecular mechanisms driving different cancer diseases and their relevance to clinical treatment options.
The core element of the programme covers a wide spectrum of research activities, starting from the identification of novel targets, through their validation in pre-clinical tumour models, and ultimately their validation in early phase clinical trials. As part of this MSc Programme, you will learn how to design, plan and set-up translational cancer studies. Each topic will be exemplified by ongoing translational studies within the University of Liverpool and you will directly interact with academic scientists, surgeons, oncologists and pathologists involved in these research studies. The final research project allows you to join one of our research teams to implement their project. For those aiming to pursue a PhD this will align to a specialist area of research within the Institute of Systems, Molecular, and Integrative Biology (ISMIB).
This MSc in Cancer Biology and Therapy programme takes a "bench to bedside" approach to enable you to work within a multidisciplinary environment of world leading scientists and cancer specialists to address the latest challenges in cancer research. The position of the new Clatterbridge Cancer Centre at the North of the City will also raise the profile of Liverpool as a centre of excellence and strategically connect the institutions for the benefit of both students and patients.
Career prospects
Past graduates of the School of Life Sciences have continued their academic careers as research assistants or pursued further study leading to a PhD. Graduates have also developed careers in conservation or qualified to immediately go into industries. There is a demand currently for graduates with specialisations in science or computing to enter the teaching profession. Commercial sectors such as the pharmaceutical, biotechnology and agriculture industries will be possible employers of graduates, especially with the anticipated increases in the use of next-generation sequencing and the corresponding data analysis that will be required.
This programme aims to provide you with the necessary knowledge and skills to become professional scientists in the area of cancer research.
Graduates with an MSc in Cancer Biology and Therapy are well qualified to enter a wide range of employment. These opportunities include careers for postgraduates in general, such as management, accountancy and human resources, where the skills obtained in the degree programme will be of considerable benefit. For those committed to a career as a research scientist, this programme will qualify you to be able to take up PhD studies, research posts in academia or in industry or management posts in clinical trial units.
Overview
This programme is designed to provide a high level understanding of the theory and practice of cancer research and to connect cancer-related biomedical research with clinical applications.
The programme is taught by both internationally renowned biomedical scientists and clinicians in practice, to provide in-depth scientific knowledge of the molecular mechanisms driving different cancer diseases and their relevance to clinical treatment options.
The core element of the programme covers a wide spectrum of research activities, starting from the identification of novel targets, through their validation in pre-clinical tumour models, and ultimately their validation in early phase clinical trials. As part of this MSc Programme, you will learn how to design, plan and set-up translational cancer studies. Each topic will be exemplified by ongoing translational studies within the University of Liverpool and you will directly interact with academic scientists, surgeons, oncologists and pathologists involved in these research studies. The final research project allows you to join one of our research teams to implement their project. For those aiming to pursue a PhD this will align to a specialist area of research within the Institute of Systems, Molecular, and Integrative Biology (ISMIB).
This MSc in Cancer Biology and Therapy programme takes a "bench to bedside" approach to enable you to work within a multidisciplinary environment of world leading scientists and cancer specialists to address the latest challenges in cancer research. The position of the new Clatterbridge Cancer Centre at the North of the City will also raise the profile of Liverpool as a centre of excellence and strategically connect the institutions for the benefit of both students and patients.
Career prospects
Past graduates of the School of Life Sciences have continued their academic careers as research assistants or pursued further study leading to a PhD. Graduates have also developed careers in conservation or qualified to immediately go into industries. There is a demand currently for graduates with specialisations in science or computing to enter the teaching profession. Commercial sectors such as the pharmaceutical, biotechnology and agriculture industries will be possible employers of graduates, especially with the anticipated increases in the use of next-generation sequencing and the corresponding data analysis that will be required.
This programme aims to provide you with the necessary knowledge and skills to become professional scientists in the area of cancer research.
Graduates with an MSc in Cancer Biology and Therapy are well qualified to enter a wide range of employment. These opportunities include careers for postgraduates in general, such as management, accountancy and human resources, where the skills obtained in the degree programme will be of considerable benefit. For those committed to a career as a research scientist, this programme will qualify you to be able to take up PhD studies, research posts in academia or in industry or management posts in clinical trial units.
